Blood Preparation Market Research Report - Forecast to 2029 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Blood Preparation Market 
Industry / Sector Trends

Blood Preparation Market size was valued over USD 60 billion in 2018 and is expected to witness more than 3.5% CAGR from 2019 to 2025.

U.S. blood preparation market size, by product, 2018 & 2025 (USD Million)

Rising prevalence of blood related disorders requiring blood transfusion will act as high impact rendering factor for blood preparation market growth during the forecast timeframe. Outbreak of infectious diseases such as dengue fever leads to rise in demand for platelet products and transfusion. South-east Asian countries such as Indonesia, India, Thailand and Myanmar are at highest risk of disease incidence.

Strong product pipeline of anti-thrombotic and anticoagulant drugs coupled with rising awareness about blood donation in developing countries should propel industry growth.  Furthermore, increasing number of road and occupational accidents should stimulate demand for blood and blood components leading to business growth.

Growing geriatric population base, generally suffering from chronic conditions such as liver cirrhosis will positively impact blood preparation market growth. Expanded applications of blood derivatives including application of platelet rich plasma in anti-aging therapy should boost business growth over the forecast period. However, risk of disease transmission such as syphilis, HIV, Hepatitis B and C, AIDS resulting due to blood transfusion will limit industry expansion to certain extent over the coming years.

Market Segmentation, Outlook & Regional Insights: Blood Preparation Market

Blood Preparation Market, By Product

Blood and blood components market accounted for more than 55% market share of global blood preparation market in 2018 due to increasing application of blood components and rising prevalence of bleeding disorders requiring blood transfusion.

Anti-thrombotic and anticoagulants market is anticipated to witness 3.5% CAGR over the forecast timeframe owing to growing adoption of anti-thrombotic drugs to reduce mortality due to thrombosis. As per NIH 2018 data, nearly 100,000 to 300,000 people in the U.S. die due to venous thrombosis annually. Increasing investment towards development of innovative anti-coagulant drugs should drive anti-coagulants market. Newly developed anticoagulant drugs include factor Xa inhibitor, tissue factor inhibitor, direct thrombin inhibitor, factor IX inhibitor, and novel vitamin K antagonists.

Blood Preparation Market, By Application

China blood preparation market share, by application, 2018

Based on application, the blood preparation industry is segmented into renal impairment, thrombocytosis, angina blood vessel complications and others. Pulmonary embolism (PE) and thrombocytosis markets together accounted for more than 40% market share in 2018. High incidence rate of these conditions coupled with continued clinical research studies in hematology should drive segment growth. Angina blood vessel complication segment is set witness 4.3% CAGR during the forecast period owing to increasing incidences of cardiac conditions resulting in less oxygen supply to the heart.

Blood Preparation Market, By Region

Europe blood preparation market share, by country, 2025 (USD Million)

U.S. blood preparation market dominated the industry in 2018 by accounting more than 35% market share of global blood preparation market. Well developed healthcare infrastructure, high patient awareness levels and growing incidences of thrombocytosis should drive U.S. blood preparation market. The Center for Biologics Evaluation and Research (CBER) controls and establishes standards for collection of blood & blood components used for transfusion or for manufacturing pharmaceuticals products from blood and its components in the country.

Chinas blood preparation market will experience significant growth of 4.8% over the forecast period. Increasing number of baby boomers, growing incidences of blood-related disorders and numerous initiatives taken by government to escalate number of blood donations should propel Chinese blood preparation market growth.

Key Players, Recent Developments & Sector Viewpoints: Blood Preparation Market

Some of the notable industry players operating in blood preparation market comprises of Pfizer, Bayer, Aralez Pharmaceuticals, GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Leo Pharma,  Bristol-Myers, Ionis Pharmaceuticals, Johnson and Johnson and Daiichi Sankyo. Companies are focusing on R&D for developing highly efficient and cost-effective anti-coagulant drugs to treat various blood related conditions. Companies are entering into strategic collaboration and partnership to increase their customer base as well as strengthen their product portfolio. For instance, Pfizer entered into collaboration with Bristol-Myers Squibb to commercialize and develop anticoagulants and metabolic compounds.

Blood Preparation Industry Viewpoint
 

Blood preparation industry has been experiencing growth since 1947, the scientists have been conducting research to develop superior blood anti-coagulants. Blood preparation industry possess strong product pipeline. Companies are also focusing on developing drugs required to reverse anticoagulation. For instance, In May 2018, U.S. FDA approved Andexxa, antidote for the Reversal of Factor Xa Inhibitors developed by Portola Pharmaceuticals. Moreover, introduction of new oral anticoagulants in the market will lead to lucrative market growth in near future.

Companies are investing heavily in R&D to develop superior anticoagulants to fulfil growing demand as well as gain significant market share especially in developing countries of Asia Pacific. Expanded applications of blood derivatives in aesthetic procedures such as anti-aging therapy should further stimulate business growth.

Key Industry Development

In Aug 2020, LEO Pharma A/S announced the sale of a portfolio of four non-core products to Cheplapharm for EUR 300 million. The agreement represents a milestone in the roll-out of LEO Pharmas 2030 strategy which increases the companys focus on new innovative solutions for medical dermatology.

The divested portfolio comprises four products within bone disorders/nephrology, dermatology and gynecology: One-Alpha©(Alfacalcidol), Locoid©(Cortisol), Pimafucin©(Natamycin), and Zineryt©(Erythromycin 40 mg and Zinc Acetate dihydrate). The annual turnover of the portfolio in 2019 amounted to approximately EUR 110 million.
The transaction is expected to close by December 2020, subject to satisfaction of customary closing conditions, including receipt of regulatory approvals. Following the closing, LEO Pharma and Cheplapharm will work closely together to ensure a smooth and effective transition of the products and business.

Key Insights Covered: Exhaustive Blood Preparation Market

1. Market size (sales, revenue and growth rate) of Blood Preparation industry.
2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Blood Preparation industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Blood Preparation industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Blood Preparation industry.

Research Methodology: Blood Preparation Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.